Quick Takeaways
- Invus Global Management, LLC filed SCHEDULE 13G/A for Vigil Neuroscience, Inc. Common Stock, par value $0.0001 per share (VIGL).
- Disclosed ownership: 4.9%.
- Date of event: 31 Dec 2024.
Invus Global Management, LLC - 31 Dec 2024 SCHEDULE 13G/A Report for Vigil Neuroscience, Inc. Common Stock, par value $0.0001 per share (VIGL)
- Filing Manager
- Invus Global Management, LLC
- Reporting Manager
- Raymond Debbane
- Symbol
- VIGL
- Shares outstanding
- 40,633,429 shares
- Disclosed Ownership
- 1,991,038 shares
- Ownership
- 4.9%
- Form type
- SCHEDULE 13G/A
- Filing time
- 12 Feb 2025, 16:30:03 UTC
- Date of event
- 31 Dec 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"Invus Global Management, LLC disclosed 4.9% ownership in Vigil Neuroscience, Inc. Common Stock, par value $0.0001 per share (VIGL) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 12 Feb 2025, 16:30.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (8)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Invus Public Equities, L.P. | 4.5% | 1,828,691 | 1,828,691 | 0 | /s/ Raymond Debbane | Raymond Debbane, President, Invus Public Equities Advisors, LLC, its general partner | |
| Invus Public Equities Advisors, LLC | 4.5% | 1,828,691 | 1,828,691 | 0 | /s/ Raymond Debbane | Raymond Debbane, President | |
| Invus Global Management, LLC | 4.5% | 1,828,691 | 1,828,691 | 0 | /s/ Raymond Debbane | Raymond Debbane, President | |
| Siren, L.L.C. | 4.5% | 1,828,691 | 1,828,691 | 0 | /s/ Raymond Debbane | Raymond Debbane, President | |
| Avicenna Life Sci Master Fund LP | 0.4% | 162,347 | 162,347 | 0 | /s/ Raymond Debbane | Raymond Debbane, Chief Executive Officer, Avicenna Life Sci Master GP LLC, its general partner | |
| Avicenna Life Sci Master GP LLC | 0.4% | 162,347 | 162,347 | 0 | /s/ Raymond Debbane | Raymond Debbane, Chief Executive Officer | |
| Ulys, L.L.C. | 0.4% | 162,347 | 162,347 | 0 | /s/ Raymond Debbane | Raymond Debbane, President | |
| Raymond Debbane | 4.9% | 1,991,038 | 1,991,038 | 0 | /s/ Raymond Debbane | Raymond Debbane |